Vitamin D status in patients with oropharyngeal cancer: Association with HPV status and prognosis
Oral Dis
.
2023 Mar;29(2):542-546.
doi: 10.1111/odi.13965.
Epub 2021 Jul 28.
Authors
Nancy Lyn Wilson Westmark
1
,
Hervé Sroussi
2
3
4
,
Ibon Tamayo
5
6
,
Alessandro Villa
7
Affiliations
1
Department of Stomatology, Medical University of South Carolina, Charleston, SC, USA.
2
Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA.
3
Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, MA, USA.
4
Division of Oral Medicine and Oral Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
5
Division of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
6
Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.
7
Department of Orofacial Sciences, University of California, San Francisco, CA, USA.
PMID:
34269501
DOI:
10.1111/odi.13965
No abstract available
Keywords:
human papillomavirus; oropharyngeal cancer; vitamin D.
MeSH terms
Humans
Oropharyngeal Neoplasms* / complications
Papillomaviridae
Papillomavirus Infections* / complications
Prognosis
Retrospective Studies
Vitamin D
Substances
Vitamin D